The serotonin 1A receptor (5-HT1A), a critical regulator of the brain serotonergic tone, is implicated in major depressive disorder (MDD) where it is often found to be dys-regulated. However, the extent to which stress and antidepressant treatment impact 5-HT1A expression in adults remains unclear. To address this issue, we subjected adult male BALB/c mice to unpredictable chronic mild stress (UCMS) to induce a depression-like phenotype that was reversed by chronic treatment with the antidepressant imipramine. In prefrontal cortex (PFC) and midbrain tissue, UCMS increased 5-HT1A RNA and protein levels, changes that are expected to decrease the brain serotonergic activity. The stress-induced increase in 5-HT1A expression was paralleled by a specific increase in DNA methylation of the conserved − 681 CpG promoter site, located within a Sp1-like element. We show that the − 681 CpG site is recognized and repressed by Sp4, the predominant neuronal Sp1-like factor and that Sp4-induced repression is attenuated by DNA methylation, despite a stress-induced increase in PFC Sp4 levels. These results indicate that adult life stress induces DNA methylation of a conserved promoter site, antagonizing Sp4 repression to increase 5-HT1A expression. Chronic imipramine treatment fully reversed the UCMS-induced increase in methylation of the −681 CpG site in the PFC but not midbrain of stressed animals and also increased 5-HT1A expression in the PFC of control animals. Incomplete reversal by imipramine of stress-induced changes in 5-HT1A methylation and expression indicates a persistence of stress vulnerability, and that sustained reversal of behavioral impairments may require additional pathways.
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Introduction
Major depressive disorder (MDD) affects 1 in 6 individuals during their lifetime and is influenced both by genetic and environmental factors (Northoff, 2013; Vialou et al., 2013) . A decrease in brain serotonergic activity is thought to underlie MDD (Asberg and Traskman, 1981; Jans et al., 2007; Mann, 1999 ) and altered expression of serotonergic genes has often been reported in individuals suffering from MDD. For example, reductions in 5-HT transporter (5-HTT) sites and 5-HTT-labeled axons and in 5-HT1A receptor levels have been observed in post-mortem prefrontal cortex (PFC) following suicide (Arango et al., 1995; Austin et al., 2002) and MDD (Lopez-Figueroa et al., 2004) , suggesting that cortical 5-HT neurotransmission is altered. Conversely, elevated levels of 5-HT1A autoreceptor levels have been reported in post-mortem MDD/suicide midbrain samples (Boldrini et al., 2008; Stockmeier et al., 1998) , which could mediate reduced serotonergic activity (Albert and Lemonde, 2004) . Genetic polymorphisms that alter transcription of serotonin genes including the 5-HT1A receptor gene have been associated with MDD in meta-analysis studies (Kishi et al., 2013) , and this association is strengthened in individuals subjected to early life stress (Karg et al., 2011; Zhang et al., 2009) , highlighting the concept that depression arises from the interplay of genetic and environmental factors.
Epigenetic modifications such as histone modification or DNA methylation can induce long lasting changes in gene expression that could explain the persistent and relapsing nature of depression and the need for chronic drug treatment (Tsankova et al., 2007; Vialou et al., 2013) . Social defeat was shown to decrease hippocampal expression of brainderived neurotrophic factor (BDNF) by increasing the repressive histone methylation of its promoters (Tsankova et al., 2006) . Similarly, chronic mild stress has been associated with dynamic changes in histone methylation/acetylation and GDNF gene expression in the striatum (Uchida et al., 2011) . In both paradigms, chronic imipramine treatment normalized gene expression. Persistent changes in DNA methylation have been
